Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
3
×
new york blog main
boston
boston blog main
boston top stories
deals
national top stories
new york top stories
san francisco blog main
san francisco top stories
startups
10x genomics
antisense oligonucleotide
astellas pharma
azacitidine
becton dickinson
benzodiazepines
beta-thalassemia
biogen
blackstone group
blackstone life sciences
cancer
cancer diagnostics
clinical trials
columbia university
dacogen
david goldstein
decitabine
depression
diagnostic device
dna
epi4k
epigenetics
epilepsy
epizyme
essential tremor
farydak
flagship pioneering
What
aims
3
×
drugs
medicines
new
research
adding
approach
backed
based
biotech
called
cause
ceo
company
deal
debuts
decisions
developing
diagnostic
diagnostics
epigenetic
epigenetics
epilepsy
expand
field
flagship’s
fold
genes
genetic
help
links
make
marcio
morning
mutations
nanostring
neuro
omega
physicians
praxis
Language
unset
Current search:
aims
×
biotech
×
" national blog main "
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further